Very common (incidence>10%) adverse effects include constipation, dry mouth, and drowsiness at the beginning of treatment.<ref name = "TOLVON">{{cite web | title = Tolvon Product Information | url = http://www.medicines.org.au/files/mkptolvo.pdf | author = Merck Sharp & Dohme (Australia) Pty Limited | publisher = GuildLink Pty Ltd }}</ref><ref name=UKlabel/>

 


 
Common (1%<incidence≤10%) adverse effects include drowsiness during maintenance therapy, tremor, headache, dizziness, vertigo, and weakness.<ref name = "TOLVON"/>

 


 
Uncommon (0.1%<incidence≤1%) adverse effects include weight gain.<ref name = "TOLVON"/>

 

